RS BioTherapeutics Logo.jpg
RS BioTherapeutics Selected for Presentation at American Thoracic Society’s 2024 Respiratory Innovation Summit
March 18, 2024 11:30 ET | RS BioTherapeutics
RS BioTherapeutics is pleased to announce that its submission has been selected for a poster presentation at the 2024 Respiratory Innovation Summit
Research Nester Logo.jpg
Chronic Disease Management Market revenue to reach USD 27 Billion by 2035, says Research Nester
March 13, 2024 07:30 ET | Research Nester
New York, March 13, 2024 (GLOBE NEWSWIRE) -- The global chronic disease management market size is projected to grow at a CAGR of over ~13% from 2023 to 2035. The market is expected to garner a...
Monaghan Medical Corporation
Monaghan Medical Corporation Attains ISO 14001 Certification for Environmental Management Excellence
February 27, 2024 07:00 ET | Monaghan Medical Corporation
Monaghan Medical Corporation is proud to have achieved ISO 14001 certification
Regeneron Logo.jpg
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
February 23, 2024 01:00 ET | Regeneron Pharmaceuticals, Inc.
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in...
Research Nester Logo.jpg
Pulmonary Drug Delivery Devices Market revenue to hit USD 105 Billion by 2035, says Research Nester
January 31, 2024 05:30 ET | Research Nester
New York, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The global pulmonary drug delivery devices market size is predicted to expand at ~7% CAGR between 2023 and 2035. The market is projected to garner a...
ResMed logo-fullcolor.jpg
Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally
December 07, 2023 15:34 ET | ResMed Inc.
New study shows Chronic Obstructive Pulmonary Disease (COPD) increasing globally through 2050, with 47% growth among women.
Pneumagen logo.jpg
Pneumagen Announces Successful Clinical Proof of Concept for its Broad-Spectrum Antiviral Neumifil in Phase 2 Influenza Human Challenge Study
October 02, 2023 04:00 ET | Pneumagen Ltd
Study achieves primary & secondary endpoints in a randomised, placebo-controlled challenge studyNeumifil delivers a statistically significant reduction in both symptomatic infection rate &...
Logo.png
Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key Companies - Genentech, GlaxoSmithKline, Regeneron, Sanofi, AstraZeneca, Mereo, Inmunotek
September 25, 2023 13:00 ET | DelveInsight Business Research LLP
New York, USA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Chronic Obstructive Pulmonary Disease Market to Witness Upsurge in Growth During the Forecast Period (2023–2032), Assesses DelveInsight | Key...
Transparency Market Research
Vibrating Mesh Nebulizer Market Predicted to Reach USD 719.2 million by 2031, Expanding at a CAGR of 9.2%: TMR Report
September 15, 2023 08:04 ET | Transparency Market Research
Wilmington, Delaware, United States, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global vibrating mesh nebulizer market is projected to flourish at a CAGR of 9.2% from...